The ROE as of December 2025 (TTM) for GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) is 52.46%

According to GlaxoSmithKline Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 52.46%. This represents a change of 297.47% compared to the average of 13.20% of the last 4 quarters.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Historical ROE (quarterly & annually)

How has GLAXO.NS ROE performed in the past?

The mean historical ROE of GlaxoSmithKline Pharmaceuticals Limited over the last ten years is 28.56%. The current 52.46% ROE has changed 83.70% with respect to the historical average. Over the past ten years (40 quarters), GLAXO.NS's ROE was at its highest in in the March 2022 quarter at 45.78%. The ROE was at its lowest in in the December 2019 quarter at -28.19%.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) ROE by Quarter and Year

Discovering the peaks and valleys of GlaxoSmithKline Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) Average ROE

How has GLAXO.NS ROE performed in the past?

The current ROE of GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) ROE vs. Peers

How is GLAXO.NS’s ROE compared to its peers?

GlaxoSmithKline Pharmaceuticals Limited’s ROE is less than Gland Pharma Limited (8.63%), less than Gland Pharma Limited (8.63%), less than Abbott India Limited (37.73%), less than Abbott India Limited (37.73%), less than Laurus Labs Limited (15.18%), less than Laurus Labs Limited (15.18%), less than Glenmark Pharmaceuticals Limited (8.72%), less than Glenmark Pharmaceuticals Limited (8.72%), less than Ipca Laboratories Limited (10.77%), less than Ipca Laboratories Limited (10.77%),

Build a custom stock screener for GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlaxoSmithKline Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GlaxoSmithKline Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.